| A Phase 3 Trial of JKN2401 Injection in COPD (NCT07330310) | Joincare Pharmaceutical Group Industry Co., Ltd | 2026-03-01 |
| Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza (NCT07357051) | Joincare Pharmaceutical Group Industry Co., Ltd | 2025-11-07 |
| A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD (NCT07351734) | Joincare Pharmaceutical Group Industry Co., Ltd | 2025-11-06 |
| Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD (NCT07450482) | Joincare Pharmaceutical Group Industry Co., Ltd | 2025-07-22 |
| JKN2306 in Healthy Subjects: Single Ascending Dose and Food Effect Study (NCT07412938) | Joincare Pharmaceutical Group Industry Co., Ltd | 2025-02-12 |
| DBM-1152A Inhalation Solution in Healthy Volunteers (NCT07439419) | Joincare Pharmaceutical Group Industry Co., Ltd | 2024-08-18 |
| A Phase 2 Trial of JKN24011 in COPD (NCT07440524) | Joincare Pharmaceutical Group Industry Co., Ltd | 2024-08-01 |
| DBM-1152A Inhalation Solution in Chinese Healthy Subjects (NCT07447141) | Joincare Pharmaceutical Group Industry Co., Ltd | 2023-12-24 |